140 related articles for article (PubMed ID: 28752142)
1. Clinical features of the patient with multiple primary tumors: Single center experience.
Gokyer A; Kostek O; Hacioglu MB; Erdogan B; Kodaz H; Turkmen E; Hacibekiroglu I; Uzunoglu S; Cicin I
North Clin Istanb; 2017; 4(1):43-51. PubMed ID: 28752142
[TBL] [Abstract][Full Text] [Related]
2. Synchronous and metachronous bilateral breast cancer: A long-term experience.
Ozturk A; Alco G; Sarsenov D; Ilgun S; Ordu C; Koksal U; Nur Pilanci K; Erdogan Z; Izci F; Elbuken F; Agacayak F; Aktepe F; Ozmen V
J BUON; 2018; 23(6):1591-1600. PubMed ID: 30610782
[TBL] [Abstract][Full Text] [Related]
3. Double primary malignancies: a clinical & pathological analysis report from a regional cancer institute in India.
Bagri PK; Singh D; Singhal MK; Singh G; Mathur G; Jakhar SL; Beniwal S; Sharma N; Kumar HS; Sharma A; Bardia MR
Iran J Cancer Prev; 2014; 7(2):66-72. PubMed ID: 25250152
[TBL] [Abstract][Full Text] [Related]
4. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease.
Heron DE; Komarnicky LT; Hyslop T; Schwartz GF; Mansfield CM
Cancer; 2000 Jun; 88(12):2739-50. PubMed ID: 10870056
[TBL] [Abstract][Full Text] [Related]
5. Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma.
Fante R; Roncucci L; Di GregorioC ; Tamassia MG; Losi L; Benatti P; Pedroni M; Percesepe A; De Pietri S; Ponz de Leon M
Cancer; 1996 May; 77(10):2013-21. PubMed ID: 8640664
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of second primary tumors in head and neck cancer.
Patrucco MS; Aramendi MV
Eur Arch Otorhinolaryngol; 2016 Jul; 273(7):1871-7. PubMed ID: 26119843
[TBL] [Abstract][Full Text] [Related]
7. Multiple primary neoplasms at a single institution: differences between synchronous and metachronous neoplasms.
Aydiner A; Karadeniz A; Uygun K; Tas S; Tas F; Disci R; Topuz E
Am J Clin Oncol; 2000 Aug; 23(4):364-70. PubMed ID: 10955865
[TBL] [Abstract][Full Text] [Related]
8. The results of modern surgical therapy for multiple primary lung cancers.
Adebonojo SA; Moritz DM; Danby CA
Chest; 1997 Sep; 112(3):693-701. PubMed ID: 9315801
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and survival of second primary breast carcinoma with extramammary malignancies.
Jing Y; Wang X; Sun B
Front Oncol; 2023; 13():1160370. PubMed ID: 37007094
[TBL] [Abstract][Full Text] [Related]
10. [Synchronous and metachronous myeloid and lymphoid tumors].
Melikian AL; Kolosheĭnova TI; Goriacheva SR; Subortseva IN; Vakhrusheva MV; Kolosova EN; Sudarikov AB; Abdullaev AO; Dvirnyk VN; Varlamova EIu; Kovrigina AM; Turkina AG
Ter Arkh; 2014; 86(7):37-44. PubMed ID: 25314776
[TBL] [Abstract][Full Text] [Related]
11. Bilateral synchronous breast cancer developed as metachronous malignancy after therapy of other primaries.
Kurzyński M; Mituś J; Kołodziej-Rzepa M; Sas-Korczyńska B
Ginekol Pol; 2018; 89(5):235-239. PubMed ID: 30084474
[TBL] [Abstract][Full Text] [Related]
12. Synchronous and metachronous skeletal osteosarcomas: the Norwegian Radium Hospital experience.
Brandal P; Bjerkehagen B; Bruland OS; Skjeldal S; Bogsrud TV; Hall KS
Acta Oncol; 2009; 48(8):1165-72. PubMed ID: 19863225
[TBL] [Abstract][Full Text] [Related]
13. Triple Primary Malignancies: Tumor Associations, Survival, and Clinicopathological Analysis: A 25-Year Single-Institution Experience.
Almasan I; Piciu D
Healthcare (Basel); 2023 Mar; 11(5):. PubMed ID: 36900742
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of synchronous and metachronous multiple primary lung cancers: systematic review and meta-analysis.
Jiang L; He J; Shi X; Shen J; Liang W; Yang C; He J
Lung Cancer; 2015 Mar; 87(3):303-10. PubMed ID: 25617985
[TBL] [Abstract][Full Text] [Related]
15. Synchronous and metachronous liver metastases in patients with colorectal cancer-towards a clinically relevant definition.
Engstrand J; Strömberg C; Nilsson H; Freedman J; Jonas E
World J Surg Oncol; 2019 Dec; 17(1):228. PubMed ID: 31878952
[TBL] [Abstract][Full Text] [Related]
16. Single and multiple metachronous osteosarcoma tumors after therapy.
Jaffe N; Pearson P; Yasko AW; Lin P; Herzog C; Raymond K
Cancer; 2003 Dec; 98(11):2457-66. PubMed ID: 14635081
[TBL] [Abstract][Full Text] [Related]
17. Receptor characteristics of the second tumor in synchronous versus metachronous breast cancer.
Bu-Ali H; Solh M; Kapur A; Mittal V
Am Surg; 2008 Aug; 74(8):702-5; discussion 706. PubMed ID: 18705570
[TBL] [Abstract][Full Text] [Related]
18. Multiple primary lung cancers.
Ribet M; Dambron P
Eur J Cardiothorac Surg; 1995; 9(5):231-6. PubMed ID: 7662375
[TBL] [Abstract][Full Text] [Related]
19. Utility of Genomic Analysis in Differentiating Synchronous and Metachronous Lung Adenocarcinomas from Primary Adenocarcinomas with Intrapulmonary Metastasis.
Saab J; Zia H; Mathew S; Kluk M; Narula N; Fernandes H
Transl Oncol; 2017 Jun; 10(3):442-449. PubMed ID: 28448960
[TBL] [Abstract][Full Text] [Related]
20. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
